AI assistant
Enveric Biosciences, Inc. — Director's Dealing 2017
May 24, 2017
35460_dirs_2017-05-23_e93a2fb9-16a9-4276-bc51-eabf3db6d2cb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMERI Holdings, Inc. (AMRH)
CIK: 0000890821
Period of Report: 2017-05-19
Reporting Person: Langer Arthur M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-19 | Common Stock | M | 4992 | — | Acquired | 69862 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-19 | Restricted Stock Unit | $ | M | 4992 | Acquired | Common Stock (4992) | Direct |
Footnotes
F1: As previously disclosed in filings with the Securities and Exchange Commission, represents stock units ("RSUs") granted as incentive compensation pursuant to the Issuer's 2015 Equity Incentive Award Plan. Each RSU represents the right to receive, at settlement, one share of the Issuer's common stock. The RSUs vested in full based on the terms of a Restricted Stock Unit Agreement between the Issuer and the Reporting Person.
F2: On May 19, 2017, 4,992 shares of the Issuer's common stock were issued in settlement of the RSUs described in footnote (1) above.